Skip to Main

Adina Symreng joined Boston Consulting Group in September 2020. She is a core member of both the Health Care and Principal Investors & Private Equity (PIPE) practices at the firm.

She is an expert in health care strategy, large-scale transformations, and health tech, and leads BCG’s work with payers and providers in the Nordics. Adina originally joined BCG in 2013. She left to serve global medtech company Elekta in 2018, most recently as global Head of Corporate Strategy, before returning to BCG in 2020.

As a member of the Health Care practice, Adina has worked in all aspects of health care including biopharma, medtech, health care payers and providers, life science tools, in vitro diagnostics (IVD), and investors, across Europe, the US, and the Middle East. She has had more than ten papers published in peer reviewed scientific journals.

AREAS OF EXPERTISE

EDUCATION

  • MD, Karolinska Institute, Stockholm
  • PhD in Clinical Epidemiology, Karolinska Institute, Stockholm

HONORS AND AWARDS

  • Board member of startup company OnDosis focusing on novel drug device solutions
  • Board member of Swedish Medical Association

Publications and Videos

" "

What GenAI Means for Health Care Investors

The rise of GenAI brings tremendous opportunity. But to cut through the hype and identify future winners, investors should focus on four innovation hot spots.
" "

Digital Solutions Reduce Waste in the Health Care System

When health care organizations integrate digital solutions and in-person care, they can significantly reduce three problem areas: failure to deliver optimal care, failure to coordinate care, and overtreatment.
Three medical professionals smiling at one another

Health Care Providers in Europe Need to Boost Digital Momentum

European health care companies struggle with digital maturity. We have identified four reasons for this, and key success factors for addressing these challenges.